Showing 1 - 3 results of 3 for search 'A. V. Molokov', query time: 0.02s Refine Results
  1. 1
    Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis

    Cardioprotective effects of alendronate bisphosphonate in patients with ischemic heart disease associated with type 2 diabetes mellitus and osteoporosis by S. N. Shilov, E. N. Berezikova, A. A. Popova, E. N. Samsonova, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, A. V. Molokov, I. V. Yakovleva

    Published 2021-05-01
    Get full text
    Article
  2. 2
    The effect of bisphosphonate therapy on reducing the risk of cardiovascular complications associated with chronic heart failure, type 2 diabetes and osteoporosis in postmenopausal women

    The effect of bisphosphonate therapy on reducing the risk of cardiovascular complications associated with chronic heart failure, type 2 diabetes and osteoporosis in postmenopausal... by A T Teplyakov, E N Berezikova, S N Shilov, A A Popova, E N Samsonova, I V Yakovleva, A V Molokov, E V Grakova, K V Kopeva

    Published 2019-10-01
    Get full text
    Article
  3. 3
    Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis

    Osteoprotegerin is a new independent predictor of the progression of cardiovascular pathology: chronic heart failure associated with type 2 diabetes and osteoporosis by A. T. Teplyakov, E. N. Berezikova, S. N. Shilov, A. A. Popova, I. V. Yakovleva, A. V. Molokov, E. V. Grakova, K. V. Kopeva, A. V. Svarovskaya, O. V. Garmaeva, Yu. Yu. Torim, E. I. Stepachev, V. V. Kalyuzhin

    Published 2018-12-01
    Get full text
    Article

Search Tools: